Evaluation of Melphalan Exposure in Lymphoma Patients Undergoing BEAM and Autologous Hematopoietic Cell Transplantation

Authors:

Abstract
No abstract available
Funding Information
  • National Institutes of Health (P01 CA23766)
  • Janssen Pharmaceutica
  • National Cancer Institute (P30 CA008748)
  • Angiocrine Bioscience
  • Amgen
  • Omeros Corporation
  • Johnson and Johnson
  • Takeda Pharmaceuticals U.S.A.
  • Spectrum Pharmaceuticals

This publication has 24 references indexed in Scilit: